Peptide A · Neuropeptides
Selank
Synthetic heptapeptide research material
TP-7selank acetate
Open the 10 mg price board ↗Check Selank anxiety evidence and side-effect limits ↗Research price & evidence comparisonSelank
Selank
vs Semax.
Selank and Semax are often grouped together as research neuropeptides, yet the public listings represent different synthetic peptide identities and different source records. This page compares their exact-size US research boards, seller overlap, current price ranges, availability, and document-access patterns without converting online claims into efficacy evidence.
2shared seller pages
Same10 mg / 10 mg board sizes
4rows with public evidence routes
0clinical or effect rankings
Identity before price
Two records, kept separate.
Selank is categorized here as a synthetic heptapeptide research material; Semax is categorized as a synthetic ACTH-fragment analogue research material. Their shared 10 mg comparison size is a market-normalization fact, not evidence that the two materials have equivalent composition or effects.
Peptide B · Neuropeptides
Semax
Synthetic ACTH-fragment analogue research material
ACTH(4-7)-PGPMEHFPGPSemax heptapeptide
Open the 10 mg price board ↗Check Semax human evidence and nootropic claims ↗Like-for-like fields
Commercial footprint, side by side.
Price ranges use rows marked in stock. “Public evidence route” means a seller exposed a document link; it does not establish authenticity, chain of custody, purity, sterility, or vial contents.
| Comparison field | Selank | Semax |
|---|---|---|
| Editorial family | Neuropeptides | Neuropeptides |
| Seller-listed identity | Synthetic heptapeptide research material | Synthetic ACTH-fragment analogue research material |
| Nominal board size | 10 mg | 10 mg |
| Available list range | $34.99–$37.17 | $32.99–$50.00 |
| Median available price | $36.08 | $34.99 |
| Lowest available / mg | $3.50 | $3.30 |
| Available rows | 2 of 3 | 3 of 3 |
| Public evidence routes | 2 rows | 2 rows |
| Evidence only on request | 1 rows | 1 rows |
| Available-price spread | 6% | 52% |
| Snapshot checked | Jul 23, 2026 | Jul 23, 2026 |
Unit warning
Per-milligram figures normalize the seller’s nominal quantity only. They are not a cross-compound value, potency, effect, or dose comparison.
Seller overlap
Where the current boards intersect.
Both belong to the neuropeptide family in the research index and are frequently stocked by the same specialist sellers, creating a useful commercial comparison but a high risk of over-reading seller descriptions.
- Pepta Labs
- Purgo Labs
- Core Peptides
- Prime Peptides
Three reading rules
What keeps this comparison honest.
- 01
Use aliases to confirm the exact peptide identity before opening a seller source.
- 02
Compare price, availability, and document access as separate dimensions rather than one quality score.
- 03
Claims about cognition, mood, anxiety, or personal outcomes are outside this research-price comparison.
Official context boundary
Read the source behind each category note.
These official context records explain why Peptide Local keeps research listings outside medical and approved-product lanes. They do not certify any seller or material.
FDA lists selank acetate (TP-7) among bulk substances that may present significant safety risks in compounding and says it lacks important information about safety when administered to humans.
Read the FDA source ↗FDA lists Semax among bulk substances that may present significant safety risks in compounding and says important safety information is lacking for routes of administration in humans. Seller listings remain research-material claims.
Read the FDA source ↗Continue comparing